Search Within

Allison Gordon

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (2)
  3. Research Letter (1)
Groups
  1. Department of Medicine (6)
  2. Department of Pathology and Laboratory Medicine (6)
  3. Dermatology (6)
  4. Dermatology Service (6)
  5. Division of Subspecialty Medicine (6)
  6. Melanoma Disease Management Team (6)

More Groups

People
  1. Alina Markova (3)
  2. Alyce Kuo (2)
  3. Andrea Moy (2)
  4. Carlie Sigel (2)
  5. Eileen O'Reilly (2)
  6. Joanne Chou (2)

More People

Years
  1. 2025 (1)
  2. 2023 (2)
  3. 2022 (3)
Publications
  1. Journal of Clinical Oncology (2)
  2. Cancer Medicine (1)
  3. JAAD Case Reports (1)
  4. Journal for ImmunoTherapy of Cancer (1)
  5. Leukemia and Lymphoma (1)
Publishers
  1. American Society of Clinical Oncology (2)
  2. Biomed Central Ltd (1)
  3. Elsevier Inc. (1)
  4. Taylor & Francis Group (1)
  5. Wiley Blackwell (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Use of dupilumab to manage a grade 3 cutaneous adverse effect from enfortumab vedotin/pembrolizumab treatment in a patient with metastatic urothelial carcinoma
    Journal Article

    Gillis, M. C.; Weir, V. R.; Lezcano, C.; Iyer, G.; Gordon, A.
    JAAD Case Reports (2025)

    Fulltext@MSK | Save
  • Management of immune-related cutaneous adverse events with dupilumab
    Journal Article

    Kuo, A. M. S.; Gu, S.; Stoll, J.; Moy, A. P.; Dusza, S. W.; Gordon, A.; Haliasos, E. C.; Janjigian, Y.; Kraehenbuehl, L.; Quigley, E. A.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Pancreatic cancer: Cutaneous metastases, clinical descriptors and outcomes
    Journal Article

    Gu, L.; Mehta, P. P.; Rao, D.; Rotemberg, V.; Capanu, M.; Chou, J.; Lin, S.; Sigel, C. S.; Busam, K. J.; Boyce, L.; more...
    Cancer Medicine (2023)

    Fulltext@MSK | Save
  • Interim analysis of a single-center, single-arm, prospective phase 2 study to evaluate the efficacy and safety of benralizumab for alpelisib rash in metastatic PIK3CA-mutant, hormone receptor-positive breast cancer
    Meeting Abstract

    Lacouture, M. E.; Pan, A.; Dranitsaris, G.; Harris, U.; Chandarlapaty, S.; Dang, C. T.; Gajria, D.; Gordon, A.; Iyengar, N. M.; Robson, M. E.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Dupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma
    Research Letter

    Kuo, A. M.; Hassoun, H.; Shah, U.; Gordon, A.; Hollmann, T. J.; Landau, H. J.; Lezcano, C.; Mailankody, S.; Tan, C. C.; Lesokhin, A. M.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Pancreatic cancer: Cutaneous metastases, clinical descriptors and outcomes
    Meeting Abstract

    Gu, L.; Paras, M.; Rao, D.; Rotemberg, V.; Capanu, M.; Chou, J. F.; Sigel, C. S.; Busam, K. J.; Boyce, L.; Gordon, A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save